Krka Again Banned From Selling Donepezil in Norway
Novo Mesto, 15 December - The Swedish subsidiary of the Slovenian generics maker Krka has again been banned from marketing Donepezil in Norway over patent violation. The same demand for a temporary injunction was meanwhile rejected in Denmark in Krka's favour, Krka reported on Wednesday.
The rest of this news item is available to subscribers.
The news item consists of 471 characters (without spaces) or 94 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.